Authors/Disclosures
|
Carly Siskind, MS
|
Ms. Siskind has nothing to disclose. |
|
Fiorella Speziani
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Michael E. Shy, MD, FAAN
(University of Iowa)
|
Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics. |
|
Tara Nazareth
(Mallinckrodt Pharmaceuticals)
|
No disclosure on file |
|
Stephan Zuchner, MD, FAAN
(University of Miami School of Medicine)
|
Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care. |
|
Martin Valis, MD
|
Dr. Valis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Valis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. |